Study identification

PURI

https://redirect.ema.europa.eu/resource/50136

EU PAS number

EUPAS50135

Study ID

50136

Official title and acronym

Bio-psycho-social characteristics of patients with migraine. A cross-sectional review of depersonalized data from the German Pain e-Registry. (BIOMIC)

DARWIN EU® study

No

Study countries

Germany

Study description

Migraine is a common headache disorder and one of the most disabling disorders globally. It is responsible for more than 50% of all years lost due to neurological disorder-related disability and is the first cause of disability in patients younger than 50 years. Migraine significantly impacts physical/biological, psychological, as well as social/occupational function. Its global prevalence in males vs. females, is 9.8% vs. 18.9%, respectively (overall prevalence is 14.4%). The incidence of migraine peaks at 35–45 years, and the female to male ratio is estimated to be three to one in reproductive ages. Although migraine is associated with a considerable burden, it can be well controlled using pharmacological and non-pharmacological approaches if treatment approaches follow current guidelines and evidence-based treatments.

Study status

Finalised
Research institutions and networks

Institutions

Contact details

Michael Ueberall

Primary lead investigator
Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Data analysis start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Other

More details on funding

German Pain Association, IFNAP - private Institute of Neurological Sciencess
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable